SWKH - SWK Holdings Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
10.90
+0.10 (+0.93%)
At close: 2:38PM EST
Stock chart is not supported by your current browser
Previous Close10.80
Open10.90
Bid0.00 x 0
Ask0.00 x 0
Day's Range10.90 - 10.90
52 Week Range9.85 - 11.90
Volume990
Avg. Volume2,637
Market Cap142.219M
Beta0.27
PE Ratio (TTM)4.02
EPS (TTM)2.71
Earnings DateMar 19, 2018 - Mar 23, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.50
Trade prices are not sourced from all markets
  • Zacks Small Cap Researchlast month

    OPNT: Will Begin Receiving 90% of NARCAN® Nasal Spray Royalties in 1Q18

    On December 20, 2017, Opiant Pharmaceuticals, Inc. (OPNT) announced that it expects to begin receiving 90% of royalty and milestone payments related to the sale of NARCAN® Nasal Spray beginning in the first quarter of 2018. On December 15, 2016, Opiant Pharmaceuticals, Inc. (OPNT) announced an agreement with SWK Holdings Corporation whereby SWK acquired the rights to certain royalty and milestone payments related to the sale of NARCAN® Nasal Spray for an initial payment of $13.7 million and the potential for an additional $3.75 million if certain future net sales milestones were met.

  • GlobeNewswire2 months ago

    SWK Holdings Corporation Announces 2017 Third Quarter Financial Results

    Total revenues of approximately $5.5 million for the third quarter of 2017 compared to $4.2 million for the third quarter of 2016. Net income attributable to SWK Shareholders of $2.8 million, or $0.21 ...

  • SWK Holdings Corp. :SWKH-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017
    Capital Cube4 months ago

    SWK Holdings Corp. :SWKH-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017

    Categories: Yahoo FinanceGet free summary analysis SWK Holdings Corp. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 5.74 million, Net Earnings of USD 3.41 million. Change in operating cash flow of -41.76% compared to same period last year is about the same as change in earnings, likely no significant ... Read more (Read more...)

  • Zacks Small Cap Research4 months ago

    OPNT: Estimating When Royalties to NARCAN® Nasal Spray Revert Back to Opiant

    On December 15, 2016, Opiant Pharmaceuticals, Inc. (OPNT) announced an agreement with SWK Holdings Corporation whereby SWK acquired the rights to certain royalty and milestone payments related to the sale of NARCAN® Nasal Spray for an initial payment of $13.7 million and the potential for an additional $3.75 million if certain future net sales milestones are met. On August 10, 2017, Opiant announced an additional $3.75 million payment from SWK related to the royalty monetization agreement related to the sale of NARCAN® Nasal Spray signed between Opiant and SWK in December 2016. According to the agreement, the $3.75 million payment was due to Opiant upon Adapt Pharma recording $25 million in cumulative net sales of NARCAN® Nasal Spray for any two consecutive quarters from Oct. 1, 2016 to Sep. 30, 2017.

  • Zacks Small Cap Research5 months ago

    OPNT: Uplists to NASDAQ

    By David Bautz, PhD NASDAQ:OPNT Opiant Uplists to the Nasdaq Stock Exchange On August 28, 2017, Opiant Pharmaceuticals Inc. (NASDAQ:OPNT) announced its shares of common stock were approved for listing ...

  • Zacks Small Cap Research5 months ago

    OPNT: Receives Additional $3.75 Million Payment From NARCAN® Nasal Spray Royalty Monetization

    On August 10, 2017, Opiant Pharmaceuticals Inc. (OPNT) announced an additional $3.75 million payment from SWK Holdings Corporation related to the royalty monetization agreement related to the sale of NARCAN® Nasal Spray signed between Opiant and SWK in December 2016. According to the agreement, the $3.75 million payment was due to Opiant upon Adapt Pharma recording $25 million in cumulative net sales of NARCAN® Nasal Spray for any two consecutive quarters from Oct. 1, 2016 to Sep. 30, 2017. The royalty monetization agreement with SWK stipulates that SWK will receive all royalties on the sale of NARCAN® Nasal Spray up to $26.25 million dollars.

  • Imprimis Pharmaceuticals Announces $16 Million Debt Facility with SWK Holdings
    PR Newswire6 months ago

    Imprimis Pharmaceuticals Announces $16 Million Debt Facility with SWK Holdings

    SAN DIEGO, July 20, 2017 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (IMMY), an ophthalmology-focused pharmaceutical company, today announced it has entered into a $16 million senior secured non-dilutive term loan agreement with SWK Funding LLC and its partners. SWK Funding LLC is a subsidiary of SWK Holdings Corporation, a healthcare focused investment firm.

  • SWK Holdings Corp. :SWKH-US: Earnings Analysis: Q1, 2017 By the Numbers : June 13, 2017
    Capital Cube7 months ago

    SWK Holdings Corp. :SWKH-US: Earnings Analysis: Q1, 2017 By the Numbers : June 13, 2017

    Categories: Yahoo FinanceGet free summary analysis SWK Holdings Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of SWK Holdings Corp. – American Express Company, OneMain Holdings, Inc. and Fairfax India Holdings Corp (AXP-US, OMF-US and FFXDF-US) that have also reported for this period. Highlights Summary ... Read more (Read more...)

  • Zacks Small Cap Research10 months ago

    OPNT: Looking to Have a Transformative 2017

    During the quarter, the company signed an agreement with SWK Holdings Corporation whereby SWK acquired the rights to certain royalty and milestone payments related to the sale of NARCAN® Nasal Spray for an initial payment of $13.7 million and the potential for an additional $3.75 million if certain future net sales milestones are met. Once SWK receives back 1.5 times their investment, Opiant will receive at least 90% of future NARCAN® royalties and milestone payments. Total revenue for the fiscal second quarter was $13.535 million, compared to $6.86 million during the three months ending Jan. 31, 2016.

  • SWK Holdings Corp. :SWKH-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
    Capital Cube10 months ago

    SWK Holdings Corp. :SWKH-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017

    Categories: Yahoo Finance Get free summary analysis SWK Holdings Corp. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of SWK Holdings Corp. – OneMain Holdings, Inc. and Fairfax India Holdings Corp (OMF-US and FFXDF-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD ... Read more (Read more...)